Jan05Tue

Member News from ICON

Irish pharma group ICON plc carried out trial of Pfizer-BioNTech vaccine
The Irish Times

The trial, involving 44,000 participants, was largest trial of a Covid-19 vaccine

Irish clinical trials group Icon has revealed that it carried out the late-stage trial of the Pfizer-BioNTech coronavirus vaccine.

The trial, which involved 44,000 participants over a four-month period last year, was the largest trial of a Covid-19 vaccine.

Pfizer and BioNTech were the first to announce positive efficacy results from a late-stage study, and the first to receive authorisation for deployment.

Read More

Dec21Mon

Member News from Almac Group

A Souderton firm played a key role in testing Pfizer’s COVID-19 vaccine
Philadelphia Inquirer

While the fanfare surrounding Pfizer’s recently approved COVID-19 vaccine resounds throughout pandemic-stricken America, a Souderton company that played a key role in its journey from test tube to approval is helping scores of other firms in their quests for successful encores.

Since early summer, Almac has been at the heart of the far-flung and intense search for drugs to combat the coronavirus, facilitating trials for the COVID-related products of at least 80 pharmaceutical and bio-tech companies, most notably the Pfizer vaccine that on Dec. 11 won emergency-use authorization from the U.S. Food and Drug Administration.

Read More

Dec16Wed

Ibec’s Quarterly Economic Outlook Q4 2020

The latest Ibec Quarterly Economic Outlook for Q4 2020 outlines that, despite the ongoing challenge of COVID and the inevitable impact of Brexit next year, there is cause for optimism.

Recent months have again shown the continuing resilience of Ireland’s export-driven growth model during a difficult period. Ireland looks to be on course to be the only country in Europe with growing exports and potentially a growing economy in 2020. The recent progress toward an effective COVID vaccine rollout, although not a panacea, also provides some hope of a return to normality for consumer facing sectors over the next twelve months.

The Irish exporting business model is proving resilient in the face of COVID and this strong export performance will be the central pillar of the economic recovery over the coming years. The other pillar will be delivering record household savings into the domestic economy. If the right incentives and channels are found, 2021 could be an extraordinarily strong year for consumer spending which would in turn, drive a recovery in employment.

Click HERE to read the full report.